vatalanib has been researched along with Rhabdoid Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhardwaj, RD; Gnimpieba, EZ; Hoffman, MM; Messerli, SM | 1 |
1 other study(ies) available for vatalanib and Rhabdoid Tumor
Article | Year |
---|---|
Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.
Topics: Brain Neoplasms; Cell Adhesion Molecules; Cell Proliferation; Child, Preschool; Female; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Molecular Targeted Therapy; Phthalazines; Prognosis; Pyridines; Receptor Protein-Tyrosine Kinases; Rhabdoid Tumor; RNA, Small Interfering; Teratoma | 2017 |